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Abstract: This paper gives an overview of the literature data concerning specific and non 
specific inhibitors of Na+,K+-ATPase receptor. The immobilization approaches developed 
to improve the rather low time and temperature stability of Na+,K+-ATPase, as well to 
preserve the enzyme properties were overviewed. The functional immobilization of 
Na+,K+-ATPase receptor as the target, with preservation of the full functional protein 
activity and access of various substances to an optimum number of binding sites under 
controlled conditions in the combination with high sensitive technology for the detection 
of enzyme activity is the basis for application of this enzyme in medical, pharmaceutical 
and environmental research. 
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1. Introduction  
 
Molecular interactions on biomembranes play a prominent role in the communication between cells 
and in signal transduction pathways [1]. Membrane receptors serve as the main targets [2] able to 
recognize specific ligands selectively, which can trigger a cascade of functional cell responses [3-6]. 
Because of their regulatory mechanisms and their relevance in ligand - target interactions, membrane 
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receptors are, currently, the focus of detailed biophysical and biochemical investigations directed to 
elucidate the relation between ligand binding and functional properties, or to resolve structure - 
activity relationships [7].  
Biological membranes are the first fence that has to be overcome by toxic compounds targeting the 
cell. One of the most important membrane proteins is adenosinetriphosphathase (ATPase, EC 3.6.1.3), 
an integral part of a sodium-potassium pump and the largest protein complex member of P -type 
family of active cation transport proteins [8]. It is responsible for establishing and maintaining the 
electrochemical gradient in animal cells [9-11], due to the free energy resulting from the hydrolysis of 
an intracellular adenosinetriphosphate (ATP). The sodium pump contributes substantially to the 
maintenance of the ion concentration gradient throughout the membrane, and enables the animal cell to 
control its volume and actively transport carbohydrates as well as amino acids. It is also required for 
nerve and muscle excitation [8].  
The minimum functional unit of Na+,K+-ATPase is an oligomer composed of stoichiometric 
amounts of two major polypeptides, the so-called α - and β -subunits. The α-subunit, responsible for 
the catalytic and transport properties of the enzyme, is a multispanning membrane protein with a 
molecular mass of ~112,000 Da that contains the binding sites for the cations and ATP and acts as the 
receptor for specific inhibitors, cardiac glycosides such as ouabain, which are bound to the 
extracellular side of the protein at very high affinity and lead to the inhibition of enzymatic activity 
[12-14]. The β-subunit is a polypeptide that crosses the membrane once and has a molecular weight 
between 40,000 and 60,000 Da, depending on the degree of glycosylation in different tissues. The β-
subunit is essential for the normal activity of the enzyme [15], and it appears to be involved in the 
occlusion of K+ and the modulation of the K+ and Na+ affinity of the enzyme [16]. Moreover, there is a 
third γ subunit, a membrane protein with a molecular mass of 12-14 kDa that interacts only with 
Na+,K+-ATPase, thus modulating the enzyme transport activity [17,18]. The γ subunit only interacts 
with the α – β complex assembled and with functional ability, but not with separate α or β subunits 
[18]. Na+,K+-ATPase acts as a dimer  (α β-α β). The most widely accepted view related to such a 
dimmer to act is "flip-flop" model, in which both α subunits show complementary conformations [19]: 
    
E1E2 E2E1  
where E is the conformation of each α subunit. The observed co-operation between the members of the 
dimmer [20] supports this model, which postulates that, when one of the α subunits is in the E1 
conformation, the other one is necessarily in the E2. Biochemical and spectroscopic data show that 
long-range E1-E2 conformational transitions in the α-subunit mediate interactions between cytoplasmic 
domains and the cation sites in the intramembrane domain [9, 21, 22]. These transitions couple the 
scalar processes of ATP binding, phosphorylation, and dephosphorylation to the vectorial extrusion of 
three Na+ ions and uptake of two K+ ions. 
The sodium pump is characterized by a complex molecular heterogeneity that results from the 
expression and differential association of multiple isoforms of both its α- and β-subunits. Individual 
genes of four α (α1, α2, α3 and α4)-subunit isoforms and at least three β (β1, β2 and β3) -subunit isoforms 
of Na+,K+-ATPase have been identified in mammalian cells [23-25]. The different kinetic parameters 
for activating cations (Na+ and K+), the substrate ATP, and ouabain, for each Na+,K+-ATPase isozyme 
imply that each isoform has distinct properties [26-28]. The distribution of the Na+,K+-ATPase α and β 
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subunits isoforms is tissue- and developmental-specific, suggesting that they may play specific roles, 
either during development or coupled to specific physiological processes [25, 29, 30]. The α1 isoform 
is ubiquitous and it is the major isoform in the kidney and many other tissues, while the α2 isoform is 
the predominant one in skeletal muscle. All three isoforms are found in the brain, the α3 isoform is 
located essentially in neurons, while the α2 isoform is found in astrocytes and some limited neuronal 
populations. Interestingly, the α4 isoform is found exclusively in the mid region of the sperm tail [31]. 
However, the α1 and α2 isoforms carry out different physiological roles. The α2 isoform appears to be 
involved in regulating Ca2+ transients involved in muscle contraction, while the α1 isoform probably 
plays a more generalized role. It is thus possible that the α2, α3, and α4 isoforms are involved in 
specialized functions of various tissues, helping to explain their tissue- and developmental-specific 
regulation [25, 29-31].  
The expression of Na+,K+-ATPase isoforms can be altered by pathological conditions. For instance, 
in several cardiac diseases, the Na+,K+-ATPase isoform composition of the heart is modified [32]. 
Numerous studies have reported changes in Na+,K+-ATPase subunit expression and activity in the 
course of malignant transformation [33-36], including gliomas [37], with evidence that these occur at 
the very early stages of tumorigenesis [35]. Moreover, it was previously shown that both non-small 
cell lung and prostate cancer overexpress Na+,K+-ATPase α1 compared with healthy tissues [35, 36, 
38], while reduced expression of the β1 isoform is commonly observed in carcinoma and is associated 
with events involved in cancer progression [39]. Recent studies show that in addition to pumping ions, 
Na+,K+-ATPase interacts with neighboring membrane proteins and organized cytosolic cascades of 
signaling proteins to send messages to the intracellular organelles [40, 41]. Moreover, it seems that 
two pools of sodium pumps exist, i.e., one broadly distributed in the plasma membrane directly 
involved in ion exchange, and another (the one located in caveolae) implicated in the signal 
transduction in couple with tyrosine kinase Src and epidermal growth factor receptor and functions as 
a signal-transducing receptor for cardiotonic steroids [36, 38, 40, 41]. These data support the view that 
Na+,K+-ATPase could be an important target for the development of anti-cancer drugs as it serves as a 
versatile signal transducer, it is a key player in cell adhesion and the aberrant expression of Na+,K+-
ATPase and activity are implicated in the development and progression of different cancers [35-38].  
The sodium pump is specifically inhibited by a series of naturally occurring cardiac glycosides, a 
family of compounds that includes cardenolides and cardiotonic steroids. The ouabain like specific 
inhibitors of sodium pump activity primarily bind to extracellular domains of αsubunits [42]. Since 
cardiotonic steroids are the natural ligands and specific inhibitors of the sodium pump [43], this 
supports the possibility of their development as anticancer agents targeting overexpressed Na+,K+-
ATPase α subunits [35-38, 44]. 
However, the activity of Na+,K+-ATPase may be affected by various endogenous and exogenous 
factors [42-54]. The regulation of Na+,K+-ATPase activity in various tissues is under the control of a 
number of circulating hormones that impart both short- and long-term control over its activity [44, 45]. 
Also, the activity of the enzyme is dependent on the lipid status of the membrane [46]. Although the 
mechanism of the toxic effect of various Na+,K+-ATPase activity modulators has not been completely 
understood yet, this enzyme can be taken as meaningful index of cellular activity and represents a 
useful toxicological tool [54].  
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Considering the key role of sodium pump in normal functioning of most cells of higher eukaryotic 
organisms, this review is an attempt to summarize the information regarding the alterations of Na+,K+-
ATPase activity by various specific and non specific modulators, as well as the basis for application of 
this enzyme as bioanalytical tool in medical, pharmaceutical and environmental research. 
 
2. Inhibition of Na+,K+-ATPase activity 
 
There are great number of different drugs and environmental toxicants which modulate the sodium 
pump activity in the concentration dependent manner [42-54]. The most frequently investigated 
sodium pump inhibitors are natural and synthesized cardiotonic steroids and their derivatives [55], 
endogenous ouabain like inhibitors, isolates from natural plants, pharmaceutically important organic 
and inorganic compounds, antitumor drugs, biologically relevant metal ions, pesticides, herbicides and 
organic solvents. Table 1 gives the overview of some of the most potent sodium pump inhibitors from 
the group of ouabain like drugs, platinum group anticancer drugs, biologically relevant and heavy 
metal ions and agents used as herbicides and insecticides. These inhibitors will be discussed in more 
details in this chapter.  
 
Table 1. The IC50 for the representative of some characteristic groups of sodium pump 
inhibitors. 
Inhibitor IC50 (M) Tissue Method Ref. 
Cardiotonic glycosides
 Ouabain 1.5x10-9 cardiac tissue coupled enzyme assay [51] 
9.4x10-6 CHO-K1 cells FRET [181] 
digoxin a2.5x10-8 
b1.3x10-4  
rat brain SPM coupled enzyme assay [49] 
a4.6x10-6  
b1.0x10-3  
human erythrocytes spectrophotometric [67] 
Gitoxin a2.8x10-7  
b4.1x10-4  
human erythrocytes spectrophotometric [67] 
metildigoxin 2.9x10-3 rat brain SPM spectrophotometric [78] 
Pharmaceuticals
propranolol  3.7x10-3 rat brain SPM spectrophotometric [78] 
verapamil  1.9x10-3 rat brain SPM spectrophotometric [78] 
oleandrin  rat brain SPM spectrophotometric [78] 
promethazine 8.4x10-4 rat brain SPM spectrophotometric [78] 
  Metal ions   
Cu2+ 5.9x10-6 rat brain SPM bioluminiscence [163] 
Hg2+ 1.1x10-6 rat brain SPM immobilized enzyme [104] 
Cd2+ 2.0x10-6 rat brain SPM coupled enzyme assay [118] 
Pb2+ 7.0x10-6 red cell membranes spectrophotometric [118] 
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Table 1. Cont. 
Platinum anticancer drugs
[PdCl(dien)]+ 1.2x10-4 Porcine cerebral cortex spectrophotometric [101] 
[PdCl4]- 2.3x10-5 Porcine cerebral cotrex spectrophotometric [101] 
[AuCl4]- 
6.9x10-5 
5.1x10-5 
dog brain microsomes 
human kidney homogenate 
spectrophotometric [68] 
cis-platinum 7.0x10-4 Ca9-22 cells spectrophotometric [106] 
Pesticides
2,4-dichlorophenoxy-
acetic acid 
<4.0x10-3 Erythrocyte spectrophotometric [54] 
2,4,5-trichlorophenoxy-
acetic acid  
<4.0x10-3 Erythrocyte spectrophotometric [54] 
parathion a71.0x10-6 
b85.0x10-6 
pig kidney spectrophotometric [142] 
ahigh affinity; blow affinity 
 
Numerous in vitro and in vivo methods are usually used to assess the inhibition of Na+,K+-ATPase 
activity in inhibition studies, as well as the enzyme preparation from different animal or human tissues 
[44-53]. Measurement of the specific Na+,K+-ATPase activity (nanomol of inorganic phosphate, Pi, 
liberated per min per milligram of protein as well as protein content) is required to evaluate the purity 
or to determine the actual specific enzyme activity [56-58]. Enzymatic ATP hydrolysis has been 
measured by several different means, as well as the determination of adenosine diphosphate (ADP) by 
enzyme coupling [59], or by colorimetric reactions [60, 61] and spectroscopic techniques [62], 
including measurement of 32P release from [γ-32P]ATP hydrolysis [63, 64]. In general, non-radioactive 
assays are much less sensitive than the radioactive ones. The RIA (radioactive immunoassay) method 
based on 32P is technically simple enough to enable simultaneous measurement of the enzyme activity 
in large number of tubules and sufficiently sensitive to determine enzyme activity in each region of the 
nephron [59, 63]. However, in some cases the easiest, quickest and most sensitive is the 
spectrophotometric assay, based on the conversion of the released orthophosphate into molybdato-
phosphoric acid and its extraction with organic solvent [65]. This is particularly important for enzyme 
kinetics studies, were nano molar concentrations of ATP are needed. 
There are also some commercially available ATPase colorimetric assay kits [66]. These kits contain 
specially purified Pi-free ATP to ensure the lowest possible background signals. They also contain the 
additives to prevent background signals arising out of nonenzymatic ATP hydrolysis. Assays can be 
read anywhere in the wavelength range 590-660nm. 
The Na+,K+-ATPase used in the inhibition studies could be isolated from different sources (rat 
brain, dog kidney, porcine cerebral cortex, human blood) [48, 52, 54, 67]. Each choice of the Na+,K+-
ATPase source, i.e. the choice of animal species or type of tissue, as well as isolate purity  (tissue 
homogenates, cell membranes, commercial enzyme) has its assets and drawbacks. The asset of use of 
tissue homogenate in inhibition studies is that effects of enzyme activity modulators are the most 
comparable with modulator effects in vivo. Unfortunately, the data concerning molecular mechanism 
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of inhibition could not be obtained by use of tissue homogenate. To test the possibility that some tissue 
component(s) may protect enzyme, some authors compared the effects of inhibitors in homogenates 
and microsomes of the same tissues [68]. The IC50 values in homogenates were 2–5 times higher than 
the values in the respective microsomes [68, 69]. Hence, purified enzyme preparation must be used for 
molecular interaction studies between enzyme and inhibitor (e.g. type of inhibition, IC50, kinetic 
parameters), in order to avoid the false interpretation of the enzyme inhibition.  
Also, the choice of Na+,K+-ATPase source is dependent on the enzyme modulator under the 
investigation. If the tested modulator exerts the high affinity towards the certain isoenzyme, the tissue 
with target isoenzyme expressed is usually chosen. Moreover, molecular biology techniques enable 
cloning of desired isoenzymes (α and β isoforms). The drawback of this approach is the difference in 
the sensitivity of native and expressed Na+,K+-ATPase. The rat α1β1 enzyme expressed in insect cells 
is over 2-fold more sensitive and the α3β1 approximately 20-fold less sensitive to ouabain than the 
native enzyme. This difference in sensitivity between the native and expressed Na+,K+-ATPase may be 
a result of the different lipid composition environment of the enzyme [25]. 
 
2.1. Specific inhibition by cardiac glycosides 
 
It is well known that the family of compounds, that includes cardenolides and cardiotonic steroids, 
such as digitoxin, digoxin, digitoxigenin, medigoxin and some derivatives (acetyldigitoxin, 
acetyldigoxin, methyldigoxin), are very potent and specific inhibitors of Na+,K+-ATPase activity in 
heart, renal and red blood cells  [42,70-77]. When used as therapeutics, the concentrations of digitalis 
compounds produce a moderate enzyme inhibition (about 30%), since the concentrations that reach 
toxic levels inhibit over 60% of the enzyme activity [74, 78].  
 
Figure 1. Basic structure of some specific Na+,K+-ATPase inhibitors. 
 
 
The inhibition of Na+,K+-ATPase activity induced by two isomers, digoxin and gitoxin (Figure 1), 
was investigated in our laboratory [67, 75]. It is noteworthy that while digoxin is one of the most 
frequently used cardiotonic drugs, gitoxin, which has the same chemical formula, but differs in the 
position of –OH groups, exerts toxic effects. The inhibitory power of these two compounds was tested 
by their ability to alter the activity of Na+,K+-ATPase isolated from human blood erythrocyte and from 
purified commercial synaptosomal porcine cerebral cortex membranes (Figure 2). Red cell membranes 
were prepared according to the method of Post et al. [79] with certain modifications. The both enzyme 
preparations were assayed in a standard incubation medium [67, 75] in the presence or absence 
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(control) of the desired concentration of inhibitor. The reaction was allowed to precede 10 min for 
cerebral cortex and 1 h for human erythrocytes, before monitoring the enzyme activity, using standard 
spectrophotometric assay. The results show, that digoxin and gitoxin inhibited Na+,K+-ATPase in both 
preparations in a concentration dependent manner, but with diverse potency [80]. However, the human 
blood erythrocyte Na+,K+-ATPase was more sensitive to exposure to gitoxin, compared to porcine 
cerebral cortex. In addition, the biphasic inhibitory curves were obtained in both enzyme preparations, 
indicating the interference of two distinct inhibitor binding sites. The heterogeneity of digoxin sites 
has also been reported in ox and rat brain Na+,K+-ATPase and related to high and low affinity  
isoforms of  subunit [81, 82].  
 
Figure 2. Inhibition of Na+,K+-ATPase activity by digoxin (circles) and gitoxin (up 
triangles) in human  erythrocyte membrane and commercial porcine cerebral cortex (inset). 
The solid lines represent the theoretical curves assuming two-site model fit, using 
experimentally determined IC50 values for high and low affinity isoenzymes. Reproduced 
from [67]. 
 
 
The measured activity was ascribed to the overall activity of the high and low affinity isoforms. In 
the mathematical analysis of the results (Figure 2) it was assumed that the mass action principles were 
fully satisfied [67, 80] and that the plot of the total activity represents the line for “two enzymes acting 
on one substrate” [83, 84]. The computer program was set up for the analysis of the data, assuming a 
two-site model fit. In the first approximation the half maximum inhibition concentrations (IC50 values) 
for the high and low inhibitor affinity isoenzymes, respectively, were calculated by fitting the 
experimental results to the sum of two sigmoid curves. The theoretical curves for high and low affinity 
enzyme isoenzymes were derived from the approximated IC50 values by several iterations, and were 
derived from the calculated IC50 values and presented in Figure 3. It is obvious from the inhibition 
curves that the same ratio of isoenzymes was obtained in both preparations.  The high affinity of 
porcine cerebral cortex Na+,K+-ATPase of porcine cerebral cortex Na+,K+-ATPase of porcine cerebral 
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cortex Na+,K+-ATPase to digoxin and gitoxin probably can be attributed to isoenzyme(s), containing 
α3 isoform. It is well known that α3 isoform is especially abundant in the brain and some other 
vertebrate tissues [55], as well as α3 isoforms from rat brain or dog heart are the most sensitive towards 
the cardiac glycosides [25]. Western analysis of the Na+,K+-ATPase from mature human erythrocyte 
ghosts, purified by ouabain column chromatography, has shown that erythrocytes contain the α1 and 
α3 isoforms of the α subunit [55]. However, as previously shown for human Na+,K+-ATPase 
isoenzymes expressed in Xenopus oocytes, all human isoenzymes have a similar affinity for ouabain 
[26]. Finally our results can be explained by isoform-specific differences which exist in K+/ouabain 
antagonism and probably as previously shown, protect α1 but not α2 or α3 from digitalis inhibition at 
physiological K+ levels [26]. From this reason, low affinity of Na+,K+-ATPase towards digoxin and 
gitoxin can be ascribed to isoenzyme(s) containing α1 isoform, which is also present in porcine 
cerebral cortex and inhibited with similar affinity towards investigated digitalis. 
Toxicity studies of these compounds were extended by measuring the proliferation index and 
micronuclei incidence in the harvested human lymphocytes cell cultures. The correlation between the 
proliferation index and the activity inhibition (Figure 4) suggested the similar behavior of two isomers 
– specific inhibitors of Na+,K+-ATPase. On the contrary, only the increasing concentrations of gitoxin 
induced the increase of micronuclei frequency in the harvested lymphocytes cell cultures. Briefly, 
gitoxin concentration increased from 5x10-9 – 5x10-6 M induced the 3 fold increase of genetic damage 
in cell cultures. Besides, digoxin did not exert any effects on the micronucleus expression in the same 
concentration range. 
 
Figure 3. The theoretical curves for inhibition of high (open symbols) and low (solid 
symbols) affinity Na+,K+-ATPase isoenzymes induced by gitoxin and digoxin (inset). 
Circles—human ghosts membranes; up triangles—commercial porcine cerebral cortex. 
Reproduced from [67].  
 
 
The mechanism of inhibition of high affinity isoenzymes of Na+,K+-ATPase activity by ouabain 
like cardiac glycosides undergoes to the Michaelis-Menten kinetics [76, 67, 80-82]. Kinetic analysis of 
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the results showed that digoxin and gitoxin behave as noncompetitive inhibitors of Na+,K+-ATPase 
activity, which interfered with the enzyme by binding to the enzyme – substrate complex causing the 
structural distortion of the active sites [76]. 
In naturally occurring digitalis glycosides the unsaturated γ- and δ-lactones present at the 17β-
position of the steroidal skeleton are associated with high affinity for the Na+,K+-ATPase receptor [86, 
87]. Recently, it was confirmed that basicity, i.e. a strong ionic interaction between one of carboxylate 
residues present in the α-subunit of the Na+,K+-ATPase and the cationic form of some digitalis like 
derivatives is relevant for interference with enzyme activity [55, 87]. The presence of –OH groups at 
different positions of the steroidal skeleton (Figure 1) reduces, in general, the interaction energy, 
though it depends on the location and spatial disposition of such –OH groups [88, 89]. 
Also, the inhibition of porcine cerebral cortex Na+,K+-ATPase by oleandrin and its derivative 
oleandrigenin, which is structurally similar to digoxin, confirms that they likely exert their toxic 
effects through inhibition of sodium pump activity [90]. An endogenous digitalis - like factor (EDLF) 
present in human urine and plasma is an inhibitor of the cell membrane Na+,K+-ATPase [91]. Its 
concentration may increase in arterial hypertension, during body volume expansion and in prenatal life 
[92, 93]. 
 
Figure 4. Dependence of proliferation index in harvested human lymphocytes exerted to 
digoxin and gitoxin on % Na+,K+-ATPase inhibition 
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The novel cardenolide UNBS1450, obtained by hemi-synthesis from naturally occurring 2”-
oxovoruscharin [94, 95], which is known to bind to the sodium pump and display potent anti-tumor 
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activity both in vitro and in vivo in experimental models of human cancer, structurally differs  
significantly from the classic cardiotonic steroids ouabain, digitoxin, and digoxin, but demonstrates 
much higher rates of inhibition of all Na+,K+-ATPase isozymes (notably, α1β1) than classic 
cardenolides. In this study the attempt was made to propose that the sodium pump, and more 
specifically, its α1subunit, is a new target in the context of malignant glioblastoma (GBM) treatment.  
 
2.2. Platinum-anticancer drugs 
 
The complexes of platinum group elements have received much attention over last two decades, 
because of their potential antitumor activity and increasing applications in chemotherapy [96-99]. For 
the study of the reaction mechanism of platinum (II) complexes their palladium analogs are often used 
as model compounds, since they exhibit about 104–105 fold higher reactivity, while their structural and 
equilibrium behavior is very similar. Recently published results concentrated on the reactions of Pt(II) 
and Pd(II) complexes with sulphur-bonding ligands, such as L-cysteine and glutathione (GSH), which 
could be of fundamental importance for understanding the toxicity and interactions with proteins of 
related platinum complexes [100,101]. These complexes have a great affinity for substitution reactions 
of the Cl- ligand by SH-donors. The coordinative interaction between [PdCl(dien)]+ and enzyme was 
verified 1H NMR spectra (Figure 5), as well as by UV spectrophotometry. Moreover, the similarity in 
the changes in absorption spectra of [PdCl(dien)]+ in the presence of Na+,K+-ATPase and thiols (L-
cysteine and GSH)  suggested that the complex ion interacts with enzymatic sulfhydryl groups. 
 
Figure 5. 1H-NMR spectra of the reactions of [PdCl(dien)]+ (5 mM) with enzyme as a 
function of time. Reproduced from [100]. 
 
 
The time course of the enzyme – inhibitor complex formation derived from1H NMR data is 
presented in Figure 6. The kinetic analysis exhibited typical Michelis-Menten noncompetitive type of 
inhibition. It seems that substrate and inhibitor were bonded to the different sites on enzyme, and the 
binding of the inhibitor did not affect binding of the substrate. Furthermore, Na+,K+-ATPase can be 
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observed as SH-donor ligand since the enzyme has 36 SH groups which are held responsible for 
interactions of this enzyme with various metal ions [102-104].  
 
Figure. 6. Product formation during the reaction of [PdCl(dien)]+ with porcine cerebral 
cortex Na+,K+-ATPase. Calculations were performed by relative integration (estimated 
error 5%) of suitable proton signals of reaction product and starting materials during 
reaction. Reproduced from [100]. 
 
However, the stability constants of enzyme-Pd (II) complexes determined in our work 
(Ks=1/Ki104 M-1) were close to the value of overall binding constant that was reported for the 
interaction of Na+,K+-ATPase with cisplatin (K=1.93x104 M-1) [97, 98], but are also for two orders of 
magnitude lower compared to aqua complexes of heavy and transition metals [102, 103]. 
Our results reported that inhibitory effects can be prevented by –SH containing ligands. Moreover, 
the dose-dependent recovery effect on inhibited Na+,K+-ATPase activity exposed to Pd(II) complexes 
was obtained in the presence of L-cysteine and GSH [97-99]. Full recovery was achieved when 
concentration of SH-containing ligands was equal or higher than the Pd (II) complex concentration. 
The recovery of the inhibition can be explained by high potency of thiols to extrude Na+,K+-ATPase 
from the enzyme-inhibitor complex and formation of stable Pd(II)-thiol complexes [105]. Since the 
intracellular concentration of GSH is up to 8 mM, and is usually much greater than those of cysteine, 
the ability of these ligands to detoxify after chemotherapy seems to be interesting for further 
investigations.  
As mentioned above, cisplatin (cis-diaminedichloroplatinum) is also a potent anticancer drug [106-
108]. It is well known that cisplatin inhibits Na+,K+-ATPase, but rather a high cisplatin concentration 
(280-800 μM) and/or a long period of incubation (60-90 min) was required to obtain about 50% 
inhibition of enzyme activity. The toxicity of the cisplatin has been ascribed to its interactions with 
thiol groups of the proteins, and the toxic side effects of platinum antitumor complexes are probably 
the result of inactivation of certain enzymes due to binding to the thiol groups of cystein residues 
[106].  Spectroscopic evidence of cisplatin-ATPase complexes showed that at low drug concentration 
(0.1 μM), cisplatin binds mainly to the lipid portion of Na+,K+-ATPase, through lipid carbonyl group. 
At higher Pt (II) concentration, drug-enzyme binds extends to polypeptide -C=O and -C–N groups. At 
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high cisplatin concentration (1 mM), drug binding results in protein secondary structural changes, 
mainly for the α-helix, β-structure and random [107]. The evidence was provided that Na+,K+-ATPase 
α1 subunit plays an important role in the transport of cisplatin in cells [108]. 
Inhibition of Na+,K+-ATPase by chlorauric acid (Au3+) and gold sodium thiomalate (Au+) was 
studied in dog brain and kidney and in human kidney enzyme preparations [68]. The extent of 
inhibition is similar to the potency of Pt (II) and Pd(II) complexes [100, 101], as well as ouabain and 
vanadium [81, 82], the classical –SH inhibitors of the enzyme. In fact, the action of gold is more 
complex than the simple inhibition of –SH groups and can hardly be transpolated in vivo because the 
reduction of Au3+ to Au+ can occur and the two oxidation states of gold behave differently toward the 
enzyme. Au+ inhibited Na+,K+-ATPase 2 to 3 times more effectively than did Au3+. The inhibitory 
action of Au3+ (but not Au+) was potentiated by ascorbic acid, suggesting reduction of Au3+ to Au+ by 
ascorbic acid. Besides, reduced metallic gold particles may be deposited in the kidney with a loss of 
activity. However, gold is one of the most potent nonspecific inhibitors of Na+,K+-ATPase, with 
characteristics differing from other metallic inhibitors of this enzyme system [68]. 
 
2.3. Metal ions 
 
Hydrolysis of ATP catalyzed by Na+,K+-ATPase depends sensitively on the presence of metal ions, 
such as Na+, K+ and Mg2+. However, a great number of biologically important metal ions which are, at 
trace levels, necessary to support life, at elevated levels become toxic, built up in biological systems, 
and induce significant health hazards [102-104, 109-112]. Many investigators have studied the in vitro 
effects of exposure to metal ions on synaptosomes, which have more nonspecific metal binding sites 
than SPMs. For instance, Na,K-ATPase from the kidney contains 36 sulfhydril groups with 34 of them 
found in the catalytically active α subunit [113, 114]. 
Recently, we investigated the in vitro influence of some metal ions of first transition series elements 
(Zn2+, Fe2+, Co2+, Cu2+) and heavy metals (Co2+, Hg2+, Pb2+) on Na+,K+-ATPase activity using rat 
synaptic plasma membranes (SPM) in native and immobilized form as a model system [104, 115]. It 
can be assumed that induced inhibition depends sensitively on .their affinity to form complexes with 
the ligands containing –SH, –NH2 or –COOH groups, but it is now generally accepted that the most 
toxic effect of heavy metals is due to their binding to sulfhydril groups of enzymes. It is reasonable to 
assume that the ion free activation energy (∆Go') for  water  exchange in metal ion aqua complexes 
play dominant role concerning the potency of their interference to the Na+,K+-ATPase activity. 
Therefore, the metal toxicity, expressed as IC50, was correlated with the stability constants of 
corresponding metal – cysteine complex (Table 2) and also with the solubility constants of metal - S2- 
complex of respective metal sulfide. Because of affinity of many metal ions to bind to adenosine 
nucleotides, the monitoring of the concentration of MgATP2-, which is the true substrate for both 
ATPase activities, and other key species, such as Mg2+ and ATP4-, as well the free metal ion 
concentration was also required [103, 112]. 
Heavy metals, such as Pb2+, Cd2+ and Hg2+ exerted a potent inhibitory effect on Na+,K+-ATPase 
isolated from different tissues, like rat brain and rat liver, by binding avidly to sulfhydryl groups with 
similar affinities [116, 117]. Sensitivity of enzyme toward Cd2+ and Hg2+ was increased after its 
immobilization by adsorption on a nitrocellulose membrane. On contrary, the immobilization of 
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enzyme by adsorption on polystyrene microtiter plates had no affect on enzyme sensitivity toward 
same ions [104]. Inhibitory effects of Cu2+, Zn2+ and Fe2+ on bovine cerebral cortex Na+,K+-ATPase 
activity have been obtained and the extent of inhibition seemed too dependent on the presence of 
chelators [103, 112].  
 
Table 2. IC50 values (μM) for Na+,K+-ATPase inhibition by some metal ions and free 
activation energy (∆Go')  (kJ mol-1)  for water exchange and solubility constants (Kso) metal 
sulphides.  
 
Metal ion 
IC50 (μM)[103] Free activation energy 
(∆Go')(kJ mol-1 )[116] 
Solubility constant 
(log Kso)[116] Exp. Calc. 
Fe2+ 34 - 38.9 -18.7 
Co2+ 168 75 40.6 -17.5 
Cu2+ 7.1 0.6 / -33.9 
Zn2+ 22 13 29.3 -24.4 
Hg2+ 0.7  / -48.8 
Cd2+ 1  / -27.3 
Pb2+ 15  / -26.7 
Mg2+ /  44.3 / 
Na+ /  16.7 / 
K+ /  14.2 / 
    
Kinetics analysis showed that the nature of enzyme inhibition is non competitive. The inhibitory 
effects of by Fe2+, Co2+, Zn2+ and Cu2+ can be prevent by addition of strong metal-ion chelators such as  
EDTA, L-cysteine or glutathione and is dose dependent. Recovery of the Hg2+-induced inhibition was 
not achieved, even when the chelators were present at concentration above 0.01 M [103, 112].  
The synergistic effects with binary combinations of heavy metals on the activity of Na+,K+-ATPase 
using the mixtures of Cu/Zn, Cu/Fe, Zn/Fe, Pb/Cd, and Cu/Pb/Zn/Cu ions were obtained in all cases. 
Moreover, all metal ions in the mixture at concentration levels near IC50 values inhibited the enzyme 
activity completely [103]. The inhibition induced by combination of Pb with Cd was time dependent. 
Addition of 1mM EDTA in the medium assay recovered 100% of the inhibited enzyme activity [118]. 
 
2.4. Toxic organic compounds  
 
2.4.1. Herbicides 
 
Chlorinated phenols are intermediates in the production of chlorophenoxy herbicides and are also 
used directly for wood preservation [119]. These compounds inhibited the Na+,K+-ATPase of Chinese 
hamster ovary cells. The effects of chlorphenoxyl herbicides and their metabolites on Na+,K+-ATPase 
of erytrocyte plasma membrane, isolated from human blood were published. Investigated basic 
compounds 2,4-dichlorophenoxyacetic acid (2,4-D), 4-chloro-2-methylphenoxyacetic acid (MCPA), 
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and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) caused an increase in the activity of the enzyme at low 
concentration (1mM) but a decrease at higher concentration. For the metabolites (2,4-dichlorophenol, 
4-chloro-2-methylphenol, 2,4-dimethylphenol, and 2,4,5-trichlorophenol) a decrease in the activity of 
ATPase was shown [120]. The changes of Na+,K+-ATPase activity may be a result of changes in lipid 
composition and fluidity of the erythrocyte membranes, but these claims are controversial. Some 
authors suggest that a decrease in membrane fluidity (after an increase of cholesterol content) might 
cause a stimulation of Na+,K+-ATPase activity in human erythrocyte membrane. Other authors claim 
the opposite effect. Phenoxyl herbicides, as suggested by some authors may incorporate into cellular 
membrane, and perturb its structure and function [121], but also to increase the plasma membrane 
fluidity. 
Abnormalities in lipid composition and structure may cause the changes in the Na+,K+-ATPase 
activity of cell membranes [122-124]. The activation of Na+,K+-ATPase also correlates with ability for 
interactions with various phospholipids and the fluidity of the fatty acyl chains [124] of the 
surrounding membrane. The membrane-crossover experiments prove that the membrane lipids are 
important determinants of Na+,K+-ATPase molecular activity. The inhibition of erythrocyte Na+,K+-
ATPase was associated with membrane protein cross-linking and lipid peroxidation [125,126]. In 
addition, phenol compounds may induce hydroxyl radical, which might damage protein structure 
[127]. 2,4-D-induced decrease in the Na+,K+-ATPase activity was observed in analysis of the effects of 
the herbicide on human skin fibroblast [128]. A decrease in Na+,K+-ATPase activity was reported in 
vesicles of rabbit brain choroids plexus [129]. The increase in free –SH group content may imply that 
phenoxyl herbicides damage the enzyme molecule structure by disruption of disulfide bridges [130]. 
These disruptions lead to enzyme inactivation.  Both mechanisms, changes in the cellular membrane or 
protein damage lead to or result from protein conformational changes and thus, exhibit as enzyme 
activity changes.   
 
2.4.2. Insecticides 
 
It is known that ATPases are target enzyme for organochlorine pesticides, which affect conduction 
of nerve impulses [131]. The chlorinated hydrocarbon insecticide chlordecone inhibits Na,K-ATPase 
[132]. Dieldrin and methyl mercury are inhibitors of rat brain synaptosomes Na+,K+-ATPase [133, 
134]. Methyl mercury binds to sulfhydryl containing proteins [135]. 
Some organophosphorus compounds (ethion, chlorpyrifos, dimethoate and monocrotophos) are 
reported to inhibit the activity of erythrocyte and rats SPM Na+,K +-ATPase[136-139]. Parathion 
inhibited renal [140] and pig kidney Na+,K+-ATPase [141], since methyl parathion inhibited rat 
synoptosomal Na+,K+-ATPase [69]. An indirect mechanism of the interaction was proposed: these 
organophosphorous insecticides could inhibit the activity of the Na+,K+-ATPase by excluding the 
enzyme protein from its normal lipid milieu [141]. Malathion was also reported as Na+,K+-ATPase 
inhibitor [142]. Synthesized phosphorotionate 2-butenoic acid-3-(diethoxyphosphinothioyl)-methyl 
ester (RPR-II) inhibited rat brain Na+,K+-ATPase [143]. 
Inhibition of Na+,K+-ATPase by an insecticide may be due to its binding to the ATPase molecule at 
or near the ouabain site [144] or may be a result of its interaction with the dephosphorylation step of 
the phosphoryl intermediate of the enzyme [145]. Alternate modes of interaction are also possible 
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[136]. In the case of some chlorinated hydrocarbon insecticides (chlordecone), the inhibition of  
Na+,K+-ATPase in the central nervous system may be casually related to their neurotoxicity [146]. 
 
3. Principle of the application of Na+,K+-ATPase as a bioanalytical tool 
 
Since cellular membranes are among the first targets for therapeutic or toxic activity in 
pharmaceutical, medical and environmental research, Na+,K+-ATPase is an excellent model system for 
elucidation of these effects induced by different drugs and environmental toxicants. High sensitivity of 
this enzyme to broad spectrum of different agents makes it suitable for toxicological and 
environmental analysis, but the lack of selectivity makes it unsuitable for a specific sensor. However, 
several efforts to develop the Na+,K+-ATPase based biosensor or high-throughput cell-based functional 
assay for Na+,K+-ATPase, discussed in the present and next chapters, are based on enzyme 
immobilization and choice the appropriate method for enzyme activity measurements. 
Enzymes immobilized on porous or non-porous supports can be reused and show better thermal and 
chemical stability [147-150]. This is the general concept for development of biosensors. In addition, 
immobilized enzyme is easily separated from the test solution and its loss is prevented by 
immobilization. A literature survey offers several methods, such as i) physical adsorption, ii) covalent 
bonding, iii) cross-linking,  iv) inclusion and v) encapsulation for the immobilization of enzymes [151]. 
Different supports can be used for enzyme immobilization. They can be separated according to their 
chemical nature (e.g. metal colloid particles, metal oxides, synthetic or natural polymers, etc.), 
structure (thin films, particles, spheres, etc.) or dimensions of their diameters (micro-, nanometer). The 
choice of a support is in close relationship with the main purpose of immobilization.  
An immobilization technique (approach) must be carefully selected for each enzyme-support 
combination in order to preserve the enzyme properties such as structure and, consequently, enzyme 
activity and selectivity. In addition, the nature of the bond between enzyme and support has to be 
sufficiently strong to avoid lost of an enzyme after the assay and to enable multiple applications of the 
same enzyme preparation. Simultaneously, this bond has to be sufficiently flexible to enable the 
enzyme-substrate interaction and the enzyme activity. Once such a method has been developed, it can 
be stated that the particular enzyme is functionally immobilized.  
The main problem in all toxicological study involving Na+,K+-ATPase, particularly enzyme present 
in the synaptosomal plasma membranes, is the rather low time and temperature stability of the SPM 
enzyme preparations. Therefore, in order to fully utilize the sensitivity of this enzyme towards a broad 
spectrum of compounds, as discussed in previous section, it is necessary to improve its stability by 
immobilization.  
Although there is a lack of the literature data about Na+,K+-ATPase immobilization, a few 
publications concerning this problem have appeared in the last decade [104]. Procedures for 
immobilization of Na+,K+-ATPase, or more precisely, of Na+,K+-ATPase-enriched membrane 
fragments, are mostly based on the simple physical adsorption of membrane fragments to the surface 
of support, but there is also an example on the covalent cross-linking of Na+,K+-ATPase and binding to 
dextran surface.  
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3.1. Binding of Na+,K+-ATPase to microtiter plate coated with wheat germ agglutinin 
 
One of earlier studies of the immobilization of Na+,K+-ATPase utilizes the high affinity binding of 
wheat germ agglutinin to the β-subunit of Na+,K+-ATPase [152]. By this approach, affinity of wheat 
germ agglutinin for binding to sugars N-linked to proteins was utilized to achieve directional binding 
of Na+,K+-ATPase. Wheat germ agglutinin was covalently bound to the surface of microtiter plate. 
After addition of Na+,K+-ATPase and binding of its β-subunit to wheat germ agglutinin, the 
cytoplasmatic side of an enzyme was exposed on the surface. Also, activity of Na+,K+-ATPase 
measured by the hydrolysis of p-nitrophenylphosphate was preserved, as well as the sensitivity to 
ouabain. The amount of Na+,K+-ATPase bound to the microtiter plate was higher than that used in the 
direct immobilizing systems. This technique might be exploited for the screening of monoclonal 
antibodies against cytoplasmatic domains of Na+,K+-ATPase.  
 
3.2. Functional immobillization of biomembrane fragments on planar waveguids  
 
The method for the functional immobilization of Na+,K+-ATPase-rich membrane fragments isolated 
from pig kidney and from the rectal gland of dogfish, on planar metal oxide waveguides was 
developed [153]. To our best knowledge, this is the first study on the immobilization of Na+,K+-
ATPase -containing membrane discs that results with flat surface configuration and with fully 
preserved protein activity.  
To summarize, the integral membrane proteins can be successfully immobilized on the flat surface 
without application of any detergent (for instance, sodium dodecyl sulphate, SDS) for partial 
solubilization of membranes. The concept of the method is schematically presented in (Figure 7). 
Briefly, authors have prepared a biocompatible surface of by deposition of phospholipid monolayer on 
the surface of metal oxide (Ta2O5) followed by the sorption of membrane fragments on this interface. 
By this approach, the natural milieu of Na+,K+-ATPase is preserved, which enables much more 
controlled conditions for the enzyme immobilization with respect to its membrane orientation.   
Besides functional studies focused on the activity of immobilized Na+,K+-ATPase and its sensitivity 
towards ouabain, method of immobilizing Na+,K+-ATPase on the sensitized surface of metal oxide 
waveguide allowed the fluorescence study on the surface distribution of the enzyme and its orientation 
in the membrane, as well as the mapping of binding sites located on the enzyme, which in a best way 
resemble the binding of a ligand under natural conditions. Kinetic study of binding of K+-ion to the 
Na+,K+-ATPase revealed fully preserved enzyme activity and conformation after binding to the 
sensitized surface of waveguide. Although not studied so far, this method can be conveniently used for 
investigations of molecular aspects of interaction of various substrates and ligands with Na+,K+-
ATPase, but also for other integral membrane proteins, such as membrane receptors.  
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Figure 7. The concept of the functional immobilization of membrane fragments on the 
metal oxide waveguide. First step (left) formation of a biocompatible surface by self-
assembly of a lipid-monolayer. Second (right) stable sorption of membrane fragments onto 
the preformed lipid interface. Reproduced from [153]. 
 
 
In another study, uncoated surface of polymer furan was used as a support for immobilization of 
membrane fragments containing also Na+,K+-ATPase [154]. These membrane fragments were isolated 
from kidney tissue and they were immobilized on the furan surface by adsorption. However, this study 
was not focused on the functional immobilization of Na+,K+-ATPase, but to find conditions for 
scanning force microscopy (SFM) of living cells and membranes and surface with low roughness was 
obtained.  
 
3.3. Immobilization of brain Na+, K+-ATPase on nitrocellulose, glass fiber and polyvinylidene fluoride 
membranes 
 
The activity of Na+,K+-ATPase partially purified from synaptosomal plasma membranes (SPM) 
from rat brain and immobilized on the surface of three different solid supports was investigated in a 
comprehensive study of Momić et al. [115]. Nitrocellulose (NC), glass fiber (GF) and polyvinylidene 
fluoride (PVDF) membranes were used as carriers for the adsorption of the SPM Na+,K+-ATPase. The 
procedure for enzyme immobilization to these supports was simple; basically, the driving force is the 
physical adsorption either by incubation of the enzyme solution or adsorption was facilitated by the 
use of vacuum system. PVDF membrane has to be rinsed and activated with methanol prior to binding. 
Effects of the temperature and pH of the solution on the efficacy of binding were studied as well.  
The Na+,K+-ATPase was partially purified by solubilization of the SPMs with SDS. The use of SDS 
at the optimal ratio to the protein (0.2 mg SDS/mg protein) [155] resulted in an increase of the enzyme 
specific activity by 39.423±0.933 %. The enzyme preparation obtained by this procedure was used in 
the immobilization experiments. 
Enzyme stability, activity and sensitivity towards different compounds before and after 
immobilization were compared. The SPM immobilized on the NC membrane expressed the highest 
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Na+,K+-ATPase activity in comparison to other solid supports tested in this study. The mechanism of 
protein immobilization on hydrophilic surface of nitrocellulose membrane can be ascribed to both 
charge-charge interactions and weak secondary forces (van der Waals, especially hydrogen 
interactions). On the other hand, the strong hydrophobic binding of the enzyme to the PVDF and GF 
membranes most likely causes the decrease of enzyme activity. 
The time-stability of Na+,K+-ATPase immobilized to the different supports was tested at 20 ºC for a 
total period of 72 h, and the results are shown in (Figure 8). While Na+,K+-ATPase in the native 
preparation (non-adsorbed, nSPM) completely lost its activity after a period of 48 h, the enzyme SPM 
adsorbed (aSPM) on nitrocellulose showed a loss of 20% in the first 4 h and a total loss of activity 
within 72 h. The Na+,K+-ATPase adsorbed to the GF membrane was stable over the same period of 
time as the native preparation, but the percent of retained activity was much less. The activity dropped 
by about 30% in the first 2 h and then the loss of activity was 70 % within 24 h. The enzyme adsorbed 
to the PVDF membrane retained about 80 % of its activity during the first 3 h of storage, but had lost 
all its activity after 24 h. 
 
Figure 8. Stability of the Na+,K+-ATPase activity of native SPM (nSPM) and adsorbed 
SPM (aSPM) on different supports as a function of time after adsorption. Reproduced from 
[115].  
 
 
Further, the effect Cd2+, Hg2+ salts and of ß-methyldigoxin on the activity of the enzyme 
immobilized on the NC membrane was investigated. Both metal ions and digoxin induced a 
concentration-dependent inhibition of the enzymatic activity. Interestingly, the enzyme immobilized 
on the NC membrane was found to be more sensitive to Cd2+ and Hg2+ than the native protein, whereas 
the sensitivity towards digoxin remained unchanged. Most likely, the conformation of enzyme has 
changed resulting in the increased sensitivity towards heavy metals salts. On the other hand, these 
conformational changes might disturb interaction of larger molecules such as digoxin with the enzyme.  
The results obtained during the study imply the possibility to use the simple adsorption of Na+,K+-
ATPase on the NC solid supports for potential application as biosensor. A biosensor that is based on 
Na+,K+-ATPase immobilized on NC support would be easy to store and use as a part of a detection kit.  
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3.4. Immobilization of Na+,K+-ATPase on the surface of polystyrene microtiter plate 
 
Another immobilization system also developed in our laboratory is the immobilization of SPMs on 
the polystyrene microtiter plates [104]. The principle of this immobilization is also simple physical 
adsorption, i.e. incubation of isolated SPMs from rat brain for 18h at 4 º C with a polystyrene matrix - 
microtiter plates. Results demonstrated that about 10% of the protein fraction was bound to the surface 
of microtiter plate, whereas Na+,K+-ATPase and Mg-ATPase retained up to 80% of their activity after 
immobilization. Also, the sensitivity of both enzymes towards heavy metal salts was not altered after 
immobilization. The only exception was the sensitivity of Mg-ATPase for the presence of Cd2+, which 
was increased in comparison to the native enzyme.  
 
Figure 9. Stability of the Na+,K+-ATPase and Mg2+-ATPase activity of nSPM and aSPM 
as a function of time after the adsorption (weeks). Reproduced from [104].  
 
 
Astonishingly, the stability of Na+,K+-ATPase bound to the polystyrene microtiter plate was 
increased compared with native SPM preparations, but also in comparison to the enzyme immobilized 
to the NC membranes [115]. Whereas the stability of partially purified Na+,K+-ATPase from the SPMs 
immobilized on the NC membrane was measured in days, the stability of Na+,K+-ATPase and Mg2+-
ATPase in the SPMs bound to the microtiter plate could be monitored for weeks (Figure 9).  
With respect to the design of a solid support, immobilization of Na+,K+-ATPase on the microtiter 
plate has an advantage over other supports, since it enables carrying out multiple tests simultaneously 
and in rather small volumes. Moreover, simplicity of the immobilization procedure resulting in high 
binding efficiency and long enzyme stability is an additional advantage over other methods that 
require pre-treatment of a surface prior to the enzyme immobilization.  
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Taken together, the physical adsorption of Na+,K+-ATPase either on the NC membrane or on the 
surface of polystirene microtiter plate might be used as practical and comfortable systems for in vitro 
toxicological investigations.  
 
3.5. Immobilization of Na+, K+-ATPase on dextran surface  
 
Another example of the Na+,K+-ATPase immobilization is the covalent binding of the enzyme to 
the surface of dextran [156]. Prior to addition of the Na+,K+-ATPase from dog kidney or porcine 
cerebral cortex, surface of dextran was activated by ethylenediaminecarbodiimide/N-
hydroxysuccinimide (EDC/NHS) reagent. After activation of dextran surface, Na+,K+-ATPase was 
added and directly bound to the surface of dextran.  
Although the loss of an enzyme activity occurs frequently after enzyme cross-linking (i.e. 
establishment of new covalent bonds), the activity of Na+,K+-ATPase was preserved after 
immobilization on dextran surface and binding of ouabain for Na+,K+-ATPase was possible. On the 
other hand, the binding of phycotoxin palytoxin on the Na+,K+-ATPase was most probably disrupted 
after this method for Na+,K+-ATPase immobilization. Taken together, adsorption of Na+,K+-ATPase -
rich membrane fragments on different supports mostly resulted in the more stable enzyme which 
retained its activity. This indicates that binding sites for substrates, as well as its active site were 
preserved after enzyme immobilization. So far, minor drawback of immobilization of Na+,K+-ATPase 
is that the sensitivity of enzyme towards certain ligands has significantly changed, what is difference 
with respect to the physiological situation. In the case of palytoxin, Na+,K+-ATPase was found 
insensitive after immobilization on the surface of dextran. Significantly, immobilization of Na+,K+-
ATPase enabled more detailed studies of enzyme function, kinetic properties of enzyme, electric 
properties of the membrane, orientation of enzyme in the membrane, binding of antibodies and 
development of new antibodies, as well as numerous toxicological studies.  
 
4. Signal detection 
 
In the next charpter, the most commonly-applied methods and comertially available kits applied for 
the determination of native enzyme activity were overwieved and the signal detection Na+,K+-ATPase 
based biosensors for potential medical and pharmaceutical applications are presented. Besides, some 
methods that can be also applied for study of the interaction between various ligands and Na+,K+-
ATPase are shortly presented. 
 
4.1. Methods for determination of Na+,K+-ATPase activity 
 
4.1.1. Spectroscopic methods 
 
 Most of the colorimetric methods are based on the spectrophotometric determination of free 
orthophosphate (Pi) released due to the Na+,K+-ATPase catalyzed hydrolysis of ATP. Pi is usually 
transformed to a phosphomolybdate complex in an acid medium followed by a reduction with ascorbic 
acid or stannous chloride followed by complexation with basic dyes that yield colored complexes [60-
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62]. As such, only static end-point determinations can be performed by measuring released inorganic 
phosphate generated during ATP hydrolysis by ATPases during the incubation period [157]. 
The simple, sensitive and reproducible [158] method based on the reduction of a phosphomolybdate 
complex by Elon in a copper acetate buffer avoids the interference by ATP with color development. 
There is also less or no interference by other compounds usually present in ATPase assay media.  
Moreover, the determination of association, dissociation and affinity constants are much easier and 
faster compared with ELISA and RIA [63]. 
The electron spin resonance (ESR) spectra of spin-labeled lipid molecules provide a method of 
probing the molecular interactions at the protein-lipid interface in biological membranes. This method 
enables to obtain structural information upon evaluation of dipolar interaction of bound radicals as 
well as information about nucleotide binding characteristics of the proteins, such as substrate binding 
stoichiometries and affinities. Lipid spin labels have been used to study lipid-protein interactions in 
bovine and frog rod outer segment disc membranes, in Na+,K+-ATPase membranes from shark rectal 
gland, and in yeast cytochrome oxidasedimyristoyl phosphatidylcholine complexes [159]. These 
systems all display a two component ESR spectrum from 14-doxyl lipid spin-labels. One component 
corresponds to the normal fluid bilayer lipids. The second component has a greater degree of motional 
restriction and arises from lipids interacting with the protein. For the phosphatidylcholine spin label 
there are effectively 55 ± 5 lipids/200,000-dalton cytochrome oxidase, 58 ± 4 mol lipid/265,000 
Dalton Na+,K+-ATPase, and 24 ± 3 and 22 ± 2 mol lipid/37,000 dalton rhodopsin for the bovine and 
frog preparations, respectively. These values correlate roughly with the intramembrane protein 
perimeter and scale with the square root of the molecular weight of the protein. Experiments with spin 
labels of different head groups indicate a marked selectivity of Na+,K+-ATPase for stearic acid and for 
cardiolipin, relative to phosphatidylcholine. 
Reaction-induced infrared (IR) difference spectroscopy with caged ATP and Na+,K+-ATPase was 
used  to differentiate between phosphorylated and unphosphorylated states of the enzyme as well as of 
its ouabain complex [62]. The IR spectral changes upon phosphoenzyme formation were characterized 
and interpreted. The results showed that high Na+ concentrations prevented the binding of ouabain 
with high affnity, which is consistent with the results of a corresponding kinetic study employing 
spectrofluorimetry and calorimetric titrations. Changes of protein structure and protein 
microenvironment associated with partial reactions of Na+,K+-ATPase were investigated employing 
reaction-induced Fourier transform infrared (FTIR) difference spectroscopy in aqueous solution 
between 2,000 and 950 cm-1. The reaction was initiated by the ultraviolet (UV)-photochemical release 
of ATP from a precursor such as caged ATP.  Employing this method, protonation and 
phosphorylation reactions can be detected in a convenient way without using any labeling methods. 
 
4.1.2. HPLC methods 
 
The high performance liquid chromatography (HPLC) assays for determination of ATPase activity 
were developed and validated [160, 161]. The method is based on the measuring of the products of 
ATP hydrolysis (mainly ADP), released during the reaction, by HPLC. This method presents the 
important advantages for the assay of the enzymes since it is reproducible through time, perfectly 
linear, and is extremely sensitive. The substrate, ATP, was incubated with the enzyme preparation in 
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the presence of an inhibitor. After stopping the enzyme reaction, the incubation mixture was filtered 
through a membrane filter, and ADP and ATP in the filtrate were separated by HPLC. The inhibitory 
effect on the enzymatic reaction was estimated by measuring the peak area ratio of ADP to ATP on the 
chromatogram [160].  
The proposed assay method has proved to be satisfactory with respect to simplicity, sensitivity, and 
reproducibility. In addition, when ouabain was used as an inhibitor, the HPLC method was found to be 
applicable for Na+,K+-ATPase activity determination. This indicated that this HPLC assay would 
enable determination of ATPases other than Na+,K+-ATPase, when other inhibitors are employed 
instead of ouabain. 
The HPLC procedure was sensitive, precise and linear calibration graph was obtained over the 
range of protein amount of the enzyme source studied, the intra- and inter-assay variations being lower 
than 10%. Also, even when the samples were contaminated with Pi, the HPLC method allowed 
determination of ATPase activity. This method is also very versatile, since it allowed to assess the Km 
value for Ca2+ of the Ca2+,Mg2+-ATPase in some tissues [161].  
Besides, an ultra performance liquid chromatograpfy (UPLC) method for determination of ATP, 
AMP and ADP in Na+,K+-ATPase assay was developed [162]. Parallel, inorganic phosphorus (Pi) 
released from ATP was spectrophotometrically determined (Figure 10). The values that were obtained 
by the two methods revealed a significant correlation. In addition, when ouabain was used as an 
inhibitor, the HPLC method was found to be applicable for Na+,K+-ATPase activity determination 
[160]. 
 
Figure 10. Chromatogram of 5 mM ATP hydrolysis products by using UPLC and 
comparison of UPLC and spectrophotometric determination of products of ATP hydrolysis 
catalyzed by  Na+,K+-ATPase. Reproduced from [162]. 
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4.1.3. Coupled enzymatic methods 
 
There are a large number of assays in cellular and molecular biology based on measurements of 
either produced or consumed inorganic phosphate [59]. Therefore, the ability to quantitatively measure 
these phosphorous compounds can allow the assessment of the associated enzymes. ATPase assays can 
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be performed by coupled spectrophotometric assay for adenosinediphosphate (ADP) with pyruvate 
kinase, lactate dehydrogenase and luciferase.  
A bioluminescence assay was applied for fast and sensitive evaluation of heavy and transitional 
metals (Cu2+, Pb2+, Cd2+, Hg2+) effect on the rat brain synaptosomal membrane Na+,K+-ATPase 
activity [163]. The assay consists of ATP-consuming reaction catalyzed by synaptic plasma membrane 
Na+,K+-ATPase coupled to the luminescent firefly luciferase , which consumes residual ATP after the 
course of Na+,K+-ATPase reaction. The bioluminescence Na+,K+-ATPase assay was applied to study 
the effect of on rat brain Na+,K+-ATPase activity after assay optimization (Figure 11). The fast 
bioluminescence Na+,K+-ATPase assay with small sample and substrate requirements could be 
adjusted for high-throughput environmental and pharmacological screening. 
The method modified to be performed in microplates [164] is based on coupled enzymatic reaction 
with the enzyme, purine-nucleoside (orthophosphate ribosyltransferase, EC 2.4.2.1 (PNP)). This 
enzyme uses inorganic phosphate (Pi) to convert the substrate 2-amino-6-mercapto-7-methylpurine 
riboside (MESG) to ribose 1-phosphate and 2-amino-6-mercapto-7-methylpurine. The enzymatic 
removal of the ribose moiety from MESG results in a shift in the wavelength of maximum absorbance 
from 330 nm to 360 nm [64, 165]. Assuming there is no preexisting phosphate, any increase in the 
absorbance at 360 nm must be the result of Pi liberation from ATP hydrolysis. 
Assays were initiated by the addition of reaction substrate and immediately placed in a µQuant 
Scanning Microplate Spectrophotometer. Data capture and reader control were carried out using KC4 
software (BioTek Instruments). Contamination of reagents with small amounts of Pi can be accounted 
for by subtraction of a reagent blank, if the standard curve and samples all contain equivalent amounts. 
However, the use of UV transparent microplates and the subtraction of a reagent blank can virtually 
eliminate these problems. Unlike most assays that quantitate inorganic phosphate, this assay is 
performed under physiologic conditions. This allows for real-time kinetic analysis of ATP-dependent 
enzymatic reactions.  
 
Figure 11. Representative ATP standard curve for light emission as function of ATP 
concentration in the range of 1x10-10 to 1x10-5 M. Reproduced from [163]. 
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4.1.4. Fluorescence and bioluminescence methods  
 
A number of physical sensing techniques, preferentially based on fluorescence and bioluminscence 
detection and designed for high throughput screening even of unpurified synaptosomes isolated from 
weighed microsamples (2–3 mg wet weight of tissue), have been developed [164, 166]. Therefore, and 
due to the trend of integrating a larger and larger number of assays on a single detection plate [167] 
leading to increase surface/volume ratios in an assay well, surface-sensitive fluorescence techniques 
[168-170] become increasingly important. 
The method is based on fluorometric measurement of ADP formed in the course of the Na+,K+-
ATPase reaction. It is highly sensitive and can be used to determine the Na+,K+-ATPase activity of 
membrane preparations with a protein content of 0.5–1.0 μg per sample [170].  
A method to measure high-affinity binding sites for fluorescent ligands was [171] was applied to 
the determination of Na+,K+-ATPase using the fluorescent ouabain derivative anthroylouabain. The 
method consists of measurements of the fluorescence intensities of a saturating concentration of 
anthroylouabain in the presence and absence of Na+,K+-ATPase and ouabain. These data and the 
fluorescence enhancement factor upon anthroylouabain binding are used to calculate the concentration 
of binding sites. The measurements can be done in a few minutes and 10 to 100 p moles of ouabain 
sites is sufficient for accurate determinations. Because phosphorylation of Na+,K+-ATPase is necessary 
to bind anthroylouabain, only functional enzyme was detected by this method [172]. 
The fluorescence detection was applied on Na+,K+-ATPase isolated as the major protein in 
nanoparticulate membrane fragments (discs of ca. 250 nm mean diameter) from specialized tissue such 
as kidney or salt glands. In contrast to solubilized systems, the protein is in its native membrane 
environment and retains its original biomembrane orientation [153]. The isolated membrane discs, 
however, are surrounded by the same aqueous medium on both sides and are no longer capable of 
separating the two different aqueous cell compartments. A fluorescent marker, such as fluorescein-5-
isothiocyanate (FITC) specifically binds to a single lysine residue, located within the ATP binding 
domain, for monitoring binding events by fluorescence quenching [173, 167, 174]. The fluorescence of 
the labeled Na+,K+-ATPase changes characteristically upon binding of different ligands and cations 
and was also used here for the analytical detection. 
 
4.2. Na+, K+-ATPase based biosensors  
 
4.2.1. Detection of various analytes by Na+,K+-ATPase assay 
 
Na+,K+-ATPase is sensitive to a great number of different groups of analytes, including 
cardiovascular drugs, biologically important elements, heavy metals, organic solvents and some toxic 
organic compounds [102]. The possibility of using ATPase system as a biological component for 
multi-response sensing system for detection of different compounds is based on the level of change of 
enzyme activity in the presence of analytes. The series of ATPase assays containing the components as 
given in Table 3 were prepared in 96 wells microtiter plate in order to reconsider the response of the 
enzymes in the presence of the investigated compounds by single exposure. The absorbance was 
measured and compared to the control value [102].  
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Table 3. Spectrophotometric response of the colorimetric assay in the presence of single 
analytes as the function of composition of ATPases assay. Reproduced from [102]. 
 
 
aStandard concentrations for ATPase assay; b values from [102]; c summary concentration of ions. 
 
The method was applied to the determination of Na+, K+, Mg2+, and heavy metals (as the group of 
elements) in mineral water. The cuvette test was applied, and four reaction mixtures were prepared 
containing the sample. Each mixture contained the standard concentrations of medium assay 
components, excluding the target ion (Na+, K+, and Mg2+) for alkaline elements detection. After the 
colorimetric assay was added, the absorbance at 690 nm was measured and compared to the 
absorbance of the control solution Table 4). The proposed method was also applied to the quality 
control of digoxin. The tested sample of Lanoxin injection was added to the standard medium assay 
containing 1mM EDTA. The activity was measured as described, and compared to the control value. 
The results presented in Table 3 showed the same result as obtained by standard method (HPLC) with 
the mean standard deviation of 6.45%. 
However, the cuvette test for detection of analytes is simple and potentially useful for quick 
measurements outdoors, too. Consequently, the test may be put under the consideration for the quality 
control by cardiotonic drugs production, as well as for detection of ATP, K+, Mg2+ and Na+ ions in 
biological fluids. 
A simple Na+,K+-ATPase assay is described as a suitable method for testing of digoxin 
photodegradation [175]. The exposure of Na+,K+-ATPase to the photodegraded samples exhibited 
reduced inhibition of the enzyme, compared to the non irradiated samples containing equal initial 
concentrations of drug. The degree of inhibition was dependent on the irradiation time. The 
concentrations of digoxin in irradiated samples were evaluated by HPLC analysis. Excellent agreement 
of the results obtained by both methods was observed. The investigation of the influence of irradiated 
samples on Na+,K+-ATPase inhibition revealed no side products acting as Na+,K+-ATPase inhibitors. 
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Table 4. Application of ATPases assay to real samples. Reproduced from [102]. 
 
aContents were checked by standard methods; bmean of 3 replicates. 
 
4.2.2. Resonant mirror biosensor 
 
The resonant mirror biosensor was used to evaluate the binding of ouabain and palytoxin to 
immobilized Na+,K+-ATPase [125]. Na+,K+-ATPase from dog kidney or porcine cerebral cortex, was 
immobilized directly to a carboxymethyl dextran (CMD) cuvettes [156,176]. Association 
measurements were made by using an Iasys Affinity Sensor (Labsystem, UK), following the 
procedures recommended by the manufacturer. The instrument analyzes interactions occurring within 
a few hundred nanometers from the sensor surface using evanescent waves, to measure changes in 
refractive index at the sensor surface. These changes can be measured as shifts in the resonance angle, 
expressed as arc seconds. Na+,K+-ATPase was coupled to CMD cuvettes, in a total volume of 60 μL.  
 
Figure 12. Porcine cerebral cortex Na+,K+-ATPase -ouabain/PTX association. (A) 
Association curves of 10mM ouabain or 10 μM palytoxin added over immobilized Na+,K+-
ATPase. (B) Association curve after addition of 10mM ouabain (first arrow) over 
immobilized Na+,K+-ATPase. PTX of 10 mM was added 25 min later (second arrow). 
Reproduced from [156]. 
 
      
 
The optical biosensor has dual cuvette surfaces that allow simultaneous dual-channel monitoring. 
By subtracting the sensor response of the control channel, the responses caused by nonspecific binding 
and bulk refractive index changes could be corrected. The stirred cuvette system used in this 
instrument ensures that mass transport effects during binding are minimized. The data-sampling 
interval was 0.3 s and the stirring rate was 85 rpm controlled by the Iasys software. 
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A range of PTX or ouabain concentrations, were allowed to bind with the immobilized Na+,K+-
ATPase, and the association curves were monitored for 25 min (Figure 12). Subsequently, the cuvette 
was washed with PBS and the dissociation phase was monitored for 5 min. The cuvette was finally 
regenerated by washing in the presence of 0.01 M HCl. Since the instrument has a dual optical path, all 
experiments were performed in one cuvette and, simultaneously, the second cuvette was used as 
control to normalize data by subtracting the response of this control cuvette with medium from the 
response of the cuvette with toxin. When the Na+,K+-ATPase from porcine cerebral cortex was 
immobilized, the same results were obtained in the presence of different concentrations of either 
ouabain or PTX (Figure 12). Ouabain induced an association curve that reached a signal of 18.1 
arcsec, while PTX did not induce any change in the association curve. This clearly indicates that PTX 
does not modify the binding of ouabain. 
 
4.2.3. Evanescent wave fluorescence biosensor 
 
Evanescent wave sensors using planar waveguides collect fluorescence emission perpendicular to 
the waveguide whereas most fiber optic biosensors of this type collect the emitted light out the end of 
the fiber [153,177]. The optical technique based on the highly sensitive detection of surface-confined 
fluorescence in the evanescent field of the waveguide was used to investigate the interactions of the 
Na+,K+-ATPase rich membrane fragments immobilized on planar metal oxide, with cations and 
ligands. The combination with surface-confined fluorescence detection by planar waveguides allowed 
the simultaneous investigation of side-directed ligand binding and of functional properties of Na+,K+-
ATPase. After successful immobilization of the membrane fragments, the functional activity of the 
immobilized protein was probed by monitoring the fluorescence changes upon specific, side-directed 
binding of cations and ligands using the FITC-labeled ATPase. The enzyme functional activity was 
tested by selective K+ cation binding, interaction with anti-fluoerescein antibody 4-4-20, 
phosphorylation of the protein and binding of inhibitory ligand ouabain [153]. The described approach 
offers great advantages because no detergent solubilization of the protein is necessary, as is the case 
for other reconstitution procedures, because the assays can be optimized efficiently and because fast 
and reproducible measurements can be performed, due to the easy exchange of the aqueous media for 
the different assays. The orientation of the immobilized membrane fragments on the surface was 
finally concluded from the comparison of the fluorescence changes, measured with the PWG sensor, 
with those found with the same membrane sample in bulk solution. 
Fluorophore labels of the surface-bound enzyme can be selectively excited in the evanescent field. 
For example, a fluorescent marker, such as fuorescein-5-isothiocyanate (FITC) can be specifically 
bound to a single lysine residue, located within the ATP binding domain, for monitoring binding 
events by fluorescence quenching [178-180]. The fluorescence of the labeled Na+,K+-ATPase changes 
characteristically upon binding of different ligands and cations and was also used for the analytical 
detection. 
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4.2.4. Optical voltage assay of Na+,K+-ATPase 
 
Na+,K+-ATPase generates the Na+ and K+ gradients across the plasma membrane of cells, which are 
needed to establish negative resting membrane potentials. In an effort to develop a high-throughput 
cell-based functional assay for the Na+,K+-ATPase, optical techniques was used to develop a 
membrane potential assay of pump activity [181]. Wild-type CHO-K1 cells were stained with FRET-
based voltage-sensitive dyes and pump dependent changes in membrane potential were assayed on a 
VIPRTM fluorescent plate reader. Cells were incubated to block the Na+/K+ pump and to allow for 
intracellular Na+ accumulation. Addition of a K+-containing extracellular solution reactivated the 
Na+/K+ pump and produced a fluorescence resonance energy transfer (FRET) increase indicating cell 
hyper polarization. Ouabain completely blocked this effect. Electrophysiology confirmed the optical 
findings as recordings current of 175-300 pA capable of hyperpolarizing the CHOK1 cell. 
An innovative method for identifying a Na+ channel blocker generally includes providing a cell 
containing a Na+ channel [182, 183]. The channel demonstrates both transient and persistent currents. 
The cell also includes a potassium K+ channel and a Na+,K+-ATPase (Na+ pump). A fluorescent dye is 
disposed into the well. The fluorescent dye is sensitive to change in cell membrane potential in order 
to enable optical measurement of cell membrane potential. A Na+ channel blocker, to be assayed, 
screened or otherwise identified, is added to the well and stimulation current is passed through the cell 
in an amount sufficient to generate an action potential before and after the addition of the Na+ channel 
blocker. Thereafter, a change in cell membrane potential is optically measured.  
Apparatus in accordance with the invention [183] includes a screen for identifying a Na+ channel 
blocker. The screen includes at least one cell comprising a Na+ channel, the channel demonstrating 
both transient and a persistent current. In addition, the cell further comprises a potassium (K+) channel 
and a Na+,K+-ATPase (Na+) pump. At least one well containing the cell is provided. A fluorescent dye 
sensitive to change in cell membrane potential in order to enable optical measurement of cell 
membrane potential is also included. Electrodes disposed in the well are in the well are provided for 
passing a stimulating current through said cell sufficient to generate an action potential before and 
after the addition of the Na+ channel blocker, to be identified, to said cell. 
These assays can be performed using robotic systems that are frequently used for high throughput 
screens in the pharmaceutical industry. The chances for discovering novel compounds that block or 
modify persistent Na+ currents while sparing transient Na+ currents should be measurably increased. 
Compounds that are selected by the above screens may then be examined in great detail using 
conventional electrophysiological methods for further examination and ultimate selection of a lead 
structure. 
 
4.2.5. High-throughput screening assay for Na+, K+-ATPase using atomic absorption spectroscopy 
 
An innovative method of chemical analysis involving Flame Atomic Absorption Spectroscopy 
(FAAS) and Graphite Furnace Atomic Absorption Spectroscopy (GFAAS) in combination with flux 
assays to directly measure intracellular or extracellular ion concentration to analyze Na+,K+-ATPase 
activity [184] was developed. The invention pertains to experimental methodologies for 
biopharmaceutical research, particularly for the analysis of drug candidates for therapeutic effects on 
Sensors 2008, 8                    
 
 
8349
Na+,K+-ATPase. The invention describes a method of preparing sample cell cultures for analysis, and 
using a unique flux (intake of ions) assay and the techniques of flame atomic absorption spectrometry 
(FAAS) or graphite furnace atomic absorption spectrometry (GFAAS) to directly measure the 
intracellular ion content of those cell cultures, enabling the measurement of ion flux and ion channel 
activity. The method enables the measurement of ion flux through cell membrane Na+,K+-ATPase to 
provide information on Na+,K+-ATPase activity.  
The first method of preparing the cell culture samples for analysis is called the Tracer Ion Method. 
The rubidium ion and lithium ions are similar to the potassium ion and sodium ion, respectively, both 
in terms of physical and chemical properties such as molecular size and ionic charge. In view of the 
tracer ions, sodium or potassium may be called native ions. Because of these similarities, these ions are 
able to pass through many respective channels and transporters, with varying permeability coefficients. 
Measurement of the concentration of the tracer ion provides a measure of Na+,K+-ATPase activity.  
The second method for preparing cell culture samples for analysis is called the Direct Measure 
Method. The cell cultures are incubated with potassium ions instead of tracer ions. Therefore, when 
the ion concentration is eventually measured, it will be a direct measurement of potassium ion 
movement into the cell through the Na+,K+-ATPase activity. 
An advantage of this invention is that the experimental methodology provides a high throughput 
way for scientists to accurately determine the therapeutic effects of novel candidate compounds for 
screening against Na+,K+-ATPase target. 
 
Conclusions 
 
Na+,K+-ATPase is the protein specially abundant in nerve cells, and represents the excellent model 
system for elucidation of neurotoxic effects, as well as the antitumor potency of the various modulators 
of its activity. The great number of organic compounds and inorganic salts, including cardiovascular 
and anti-cancer drugs, biologically important elements, heavy metals, organic solvents and some toxic 
organic compounds, such as pesticides and herbicides, strongly modulate enzyme activity on the 
concentration dependent manner. Because of its high sensitivity to the broad spectrum of toxic 
compound, as well as potential cardiotonic and anticancer drugs, Na+,K+-ATPase activity can be taken 
as meaningful index of cellular activity and forms a useful toxicological tool in medicine, pharmacy 
and environment.  
In order to fully utilize the sensitivity of this enzyme towards a broad spectrum of compounds, its 
properties were improved by immobilization. The immobilization approaches improved rather low 
time and temperature stability of Na+,K+-ATPase, and also preserved the enzyme properties such as 
structure, enzyme activity and selectivity, particularly of the enzyme present in the synaptosomal 
plasma membranes. Procedures for immobilization of Na+,K+-ATPase are mostly based on the simple 
physical adsorption or the covalent cross-linking of membrane fragments to the surface of support, 
such as  planar waveguids, wheat germ agglutinin, nitrocellulose, glass fiber, polyvinylidene fluoride 
membranes, polystyrene microtiter plate and dextran surface.  
In this review, we have given a literature survey on:  i) the functional properties of Na+,K+-ATPase, 
ii) the inhibitory potential of a spectrum of compounds and their mechanism of action, iii) the different 
immobilization procedures applied particularly for this enzyme, as well as iv) the methods commonly 
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applied for determination of the Na+,K+-ATPase activity and for monitoring of the structural changes 
of the enzyme upon interaction with various substances. Taken together, one can conclude that the 
most important pre-requisites to apply Na+,K+-ATPase as a biological tool for applications in medical, 
pharmaceutical and environmental research already exist. First of all, the enzyme demonstrated very 
high sensitivity towards a spectrum of compounds, secondly, immobilization procedures appeared to 
be rather efficient and yield the active and stable enzyme and, finally, methods for measurement of the 
Na+,K+-ATPase activity are developed and in common use. In addition, some of the methods are very 
convenient for outdoor applications. On the other hand, lack of selectivity for various toxic compounds 
makes potential applications of Na+,K+-ATPase for enzyme-based biosensor rather difficult and 
implies its application only as a model system for sensing toxic compounds and for elucidating 
potential toxic effects. Although well known and broadly studied, Na+,K+-ATPase will hardly be 
seriously considered for development of a future biosensor.  
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